Join professionals tracking tenders & grants across 180 countries
Medicines, vaccines, pharmaceuticals and medical consumables.
3,101 open opportunities in this category
A weekly digest of only pharmaceuticals & consumables tenders and grants for where you do business.
Set Up AlertsFilter by country
Tenders and grants tagged Health-pharma by our classifier.
Here is a selection of recent tenders and grants. Register for free to view all pharmaceuticals & consumables opportunities.
Invitation to tender for the provision of a Next Gen Sequencing Platform for the Cancer Molecular Diagnostics Department within St James’s Hospital Dublin
Canterbury Regional Council is seeking proposals from experienced laboratory service providers to deliver reliable, timely and defensible environmental analysis across groundwater, surface water, soil, air, sediment and biota.This significant, long-term opportunity will support critical environmental monitoring, regulatory and compliance activities across Canterbury. The successful supplier wil...
NOTICE OF PROPOSED PROCUREMENT The Department of National Defence (DND) through the Strategic Medical Countermeasures Program on behalf of the Canadian Forces Health Services Group, has a requirement for Pralidoxime for the treatment of Canadian Armed Forces (CAF) members suspected of exposure to chemical warfare agents. The initial requirement is for the delivery of 450 doses to be delivered b...
INVITATION TO TENDER FOR THE PROVISION OF A COAGULATION ANALYTICAL PLATFORM FOR THE ST JAMES’S HOSPITAL COAGULATION LABORATORY INCORPORATING THE NATIONAL CENTRE FOR HEREDITARY COAGULATION DISORDERS 2026. https://www.etenders.gov.ie/epps/cft/prepareViewCfTWS.do?resourceId=9139907
Invitation to tender for the provision of a coagulation analytical platform for the st james’s hospital coagulation laboratory incorporating the national centre for hereditary coagulation disorders 2026.
This is to cover the supply of High Tech Homecare Medicines Services and replace current NEYPPC homecare high tech framework.
This is a tender opportunity for the Supply of Bipolar Forceps
Supply of Biologics, Biosimilars and Methotrexate Injections to NHS Scotland.
Project title: NHS Midlands & East Framework for Denosumab 60mg PFS Offer reference number: CM/TNS/26/5768 Period of framework: 01 January 2027 to 31 August 2027 with an option or options to extend (at the Authority’s discretion) for a period or periods up to a total of 16 months. Published By: Medicines Procurement and Supply Chain - NHS Medicines Value & Access, NHS England
FCL033F Single Supplier Framework Agreement for the supply and delivery of Cleaning, Paper, Personal Hygiene and Period Equality Products https://www.etenders.gov.ie/epps/cft/prepareViewCfTWS.do?resourceId=9078105
FCL033F Single Supplier Framework Agreement for the supply and delivery of Cleaning, Paper, Personal Hygiene and Period Equality Products
Canada seeks qualified third-party logistics providers to deliver end-to-end warehousing, storage, and distribution services for the Public Health Agency of Canada’s National Emergency Strategic Stockpile, supporting the safe management and timely delivery of specialized pharmaceutical products, including vaccines and therapeutics, across Canada.
STG - Hepatitis C Vehicle Mobile Unit Conversion
Advanced Contract Award Notice(ACAN) - Vaccinia Immunoglobulin intravenous (human) (VIGIV) An ACAN is a public notice indicating to the supplier community that a department or agency intends to award a contract for goods, services or construction to a pre-identified supplier, thereby allowing other suppliers to signal their interest in bidding, by submitting a statement of capabilities. If no s...
The provision of Generic Drugs - Injections/Infusions
Scotland has the highest drug and alcohol related death rates in the UK and Europe. People with substance use issues (PWSUI) often need help outside normal 'office' hours or from a distance from offices, and support is not uniformly available throughout Scotland. The support landscape in Scotland is fragmented, hard to navigate, and varies by locality. When support isn’t readily available (or i...
The MHRA is responsible for the production, storage and global distribution of biological referance materials. The Manufacturing team are responsible for the for the fill and finish of the materials, ensuring they meet the necessary specifications such as precision of fill, oxygen content, and moisture content. The aim of this tender is to identify a supplier capable of providing critical fill ...
Offer Reference number: CM/PHG/25/5738 Period of framework agreement: Dates detailed below, with an option or options to extend (at the authority’s discretion) for a period or periods up to a total of 48 months. Potential periods of call-offs under the framework agreement: CM/PHG/25/5738/01 - Oral & Non-Parenteral Products: CESW (Central/Midlands and Southwest): 1st June 2027 to 31st May 2030 (...
HP02-2025AI/02: Supply and delivery of anti-infective medicines (antibiotics, antifungal, antiprotozoal and antiviral agents) to the Department of Health for the period ending 30 September 2028
The Agency seeks to establish a supply contract for a range of qualitative enzyme immunoassay testing kits used in the batch release testing of vaccines and reference reagents. The products identified within this specification have been internally qualified and validated for use within established and validated test methods. To maintain method consistency, regulatory compliance, and data integr...
Wave 17a DLS and DNE (London South and North East and Yorkshire), Oral Products and Housekeeping Products for remaining regions The commencement of procurement and award of any subsequent contract will be subject to budgetary approval
NHS Supply Chain is preparing a national framework agreement that will support the procurement of dental consumables, clinical solutions, equipment, digital technologies, diagnostics, and practice infrastructure, structured across the following indicative lots: The following lot structure is indicative and subject to final confirmation: Lot 1: Dental Consumables & Appliances Lot 2: Specialist C...
ESPO is a trading department of Leicestershire County Council. It is a non-profit making body owned and operated jointly by six local authorities. We provide a catalogue range, providing our customers with access to over 28,000 products that cover all key areas of education and wider public sector requirements. We are establishing a catalogue framework covering the supply of cleaning chemicals ...
Oxford University Hospitals NHS Foundation Trust (OUH) is seeking to procure a managed service for the provision of a blood transfusion analyser solution with the supply of associated consumables, reagents, training and maintenance services across its hospital sites. The scope of the managed service will be delivered across the John Radcliffe Hospital (Oxford) and Horton General Hospital (Banbu...
The Police and Crime Commissioner (PCC) for Warwickshire invites tenders for the provision of a Criminal Justice Related Drug and Alcohol Referral Service for Adults. The PCC seeks to commission an experienced provider to deliver an Arrest Referral Service across police custody settings in Warwickshire, together with associated substance misuse assessment, intervention and referral services. In...
The Air Force Research Laboratory, Human Effectiveness Directorate (RH) and the United States Air Force School of Aerospace Medicine (USAFSAM), is soliciting white papers (and potentially later technical and cost proposals) on the research located in the Statements of Objectives attached to the Continuing Human Enabling, Enhancing, Restoring and Sustaining (CHEERS) Multiple Authority Announcement (MAA) Opportunity FA2384-24-S-2233.List of Attachments:1. "Open Period Solicitation 1_BAA Amend 01"2. "Attachment 1 - List of Provisions and Clauses (BAA)"Related Notice: Multiple Authority Announcement (MAA) FA238424S2233, "Continuing Human Enabling, Enhancing, Restoring and Sustaining (CHEERS)"Note: You MUST refer to the related notice identified above in order to obtain all additional attach...
This Notice of Funding Opportunity (NOFO) solicits cooperative agreement research applications to support a multidisciplinary program titled "Accelerating Product Excellence in Innovation and for Clinical Adoption" (APEx), that will facilitate advancement of promising strategies and products for tissue engineering and regenerative medicine (TE/RM). APEx will be composed of Resource Centers (RCs) and associated Interdisciplinary Translational Projects (ITPs) in the area of therapeutics (including adult stem cell-based treatments), sensors, and diagnostics. RCs will capitalize on their available clinical, scientific, industrial, regulatory and commercialization expertise, to deliver technical support, research capacity, administrative infrastructure and regulatory and commercialization su...
Funding Opportunity Title: Tech Innovation Lab Funding Opportunity Number: PAS-MOROCCO-FY26-03 Deadline for Applications: July 13, 2026 at 23:59 GMT+1 Assistance Listing Number: 19.040 Length of performance period: 12 to 18 months Number of awards anticipated: 1 award Total available funding: $200,000 pending availability of funds Type of Funding: FY26 Smith Mundt Public Diplomacy Funds Anticipated project start date: October 2026 Funding Instrument Type: Cooperative agreement. Project Performance Period: Proposed projects should be completed in 18 months or less The Department of State will entertain applications for continuation grants funded under these awards beyond the initial budget period on a non-competitive ...
Summary: The fiscal year 2026 (FY26) Amyotrophic Lateral Sclerosis Research Program (ALSRP) Therapeutic Development Award (TDA) supports research ranging from preclinical validation of therapeutic leads through U.S. Food and Drug Administration (FDA) Investigational New Drug (IND)-enabling studies. The proposed studies are expected to be empirical in nature and product-driven. Applicants with limited amyotrophic lateral sclerosis (ALS) experience are strongly encouraged to include collaborators with substantial experience in the relevant ALS model systems, endpoints and pathophysiology.Applications supported by this award must begin with lead compounds in hand and must already demonstrate proof-of-concept efficacy data in at least one appropriate preclinical model system of ALS, includi...
Summary: The fiscal year 2026 (FY26) Peer Reviewed Cancer Research Program (PRCRP) Clinical Trial Award (CTA) supports the rapid implementation of clinical trials with the potential to have a significant impact on the treatment or management of cancer within at least one of the FY26 PRCRP Topic Areas. Clinical trials proposed may evaluate promising new products, pharmacologic agents (drugs or biologics), devices, clinical guidance, and/or emerging approaches and technologies. Proposed projects may range from small proof-of-concept trials (e.g., pilot, first-in-human, phase 0) that evaluate the effects of interventions or inform the design of more advanced trials to large-scale trials (up to phase III) to determine efficacy in relevant patient populations.Distinctive Features:• Applicati...
This is a Notice of Funding Opportunity (NOFO) for a Limited Competition that will invite applications from eligible organizations to apply. Please see Section III. Eligibility for additional information. In accordance with NIH standard peer-review processes, the applications will be peer-reviewed, and only meritorious applications will be considered.
2027 LITC Grant Application Period announcementMore information may be found on the Taxpayer Advocate Website at https://www.taxpayeradvocate.irs.gov/about-us/low-income-taxpayer-clinics-litcThe grant application period is 5/6/2026-7/6/2026. Appy at https://litcgrants.treasury.govThe NOFO is attached to this announcement
Tell us about your organization and we'll tailor a plan for you.